Actinomyces gerencseriae is a Gram-positive, anaerobic bacterium that belongs to the Actinomyces genus. While Actinomyces species are commonly found in the oral cavity and gastrointestinal tract, Actinomyces gerencseriae is specifically associated with human clinical infections. It has been implicated in a variety of infections, including cervicofacial actinomycosis, an infection that primarily affects the head and neck regions. Cervicofacial actinomycosis caused by Actinomyces gerencseriae typically presents as slowly progressing, indurated abscesses or masses, often with draining sinuses. The infection is characterized by the formation of sulfur granules, which are microscopic colonies of the bacterium. Diagnosis involves clinical evaluation, imaging studies, and often, microscopic examination of purulent material. Treatment of Actinomyces gerencseriae infections typically requires a prolonged course of antibiotics, such as penicillin or amoxicillin. Surgical drainage or excision of abscesses may be necessary in some cases. The prognosis is generally favorable with appropriate and timely intervention, but delays in diagnosis and treatment can lead to chronic, debilitating disease.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France